Form 4: MANGOCEUTICALS CEO Boosts Stake, Secures New Equity

Sentiment:

Insider Transaction Report


MANGOCEUTICALS, INC. CEO Jacob D. Cohen increased his beneficial ownership through a discretionary bonus, new stock options, and a convertible note with warrants.

Capital raiseThe amendment of a $100,000 promissory note into a convertible promissory note with an 18% interest rate and the issuance of warrants to The Tiger Cub Trust (controlled by the CEO) represents a form of capital financing from a related party.

Summary

  • CEO Jacob D. Cohen transferred 200,000 shares of common stock to The Tiger Cub Trust, which he controls, on June 5, 2025, resulting in no change to his overall beneficial ownership.
  • On September 9, 2025, Mr. Cohen received a discretionary bonus of 500,000 shares of common stock for his services as CEO during 2025, issued under the company's 2022 Equity Incentive Plan.
  • On July 21, 2025, The Tiger Cub Trust amended a $100,000 promissory note into a convertible note with a conversion price of $1.785 per share, accruing interest at 18% per annum, maturing on May 2, 2026.
  • Concurrently, The Tiger Cub Trust was granted warrants to purchase 50,000 shares of common stock at an exercise price of $1.85, expiring on July 21, 2028.
  • On September 9, 2025, Mr. Cohen was granted 2,000,000 stock options with an exercise price of $2.3, vesting over 18 months, and expiring on September 9, 2035.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this filing as moderately positive, reflecting strong insider commitment and significant equity incentives for the CEO, though the high interest rate on the convertible note introduces a financial consideration.

Positives

  • CEO Jacob D. Cohen received a discretionary bonus of 500,000 shares of common stock, aligning his interests with shareholders.
  • Mr. Cohen was granted 2,000,000 stock options, further incentivizing his performance and long-term commitment to the company.
  • The vesting schedule for options includes accelerated vesting upon certain termination events or a change of control, providing management stability incentives.

Negatives

  • The convertible promissory note held by The Tiger Cub Trust accrues interest at a high rate of 18% per annum, which could be dilutive or costly for the company if converted or repaid.

Risks

  • The 18% per annum interest rate on the convertible promissory note held by a related party (Tiger Cub Trust, controlled by the CEO) represents a significant cost of capital for the company.
  • Potential future dilution from the conversion of the promissory note and exercise of warrants and stock options could impact existing shareholder value.

Future Outlook

The vesting schedule for the newly granted stock options, which includes accelerated vesting upon certain corporate events, suggests a strategic alignment of CEO incentives with long-term company performance and potential future corporate transactions.

Management Comments

  • The 500,000 shares were issued as a discretionary bonus in consideration for services rendered as Chief Executive Officer of the Issuer during 2025.
  • The options vest over 18 months with 500,000 of the options vesting upon grant and 500,000 of the options vesting on the 6th, 12th, and 18th month anniversaries of the grant date, subject to Mr. Cohen's continued service with the Company on such vesting date; and vest in full upon any termination of Mr. Cohen by the Company without cause, or by Mr. Cohen for good reason, or upon a change of control of the Company.

Industry Context

StockSavvy.ai notes that insider transactions, particularly those involving significant equity grants and convertible debt, are common mechanisms for aligning executive interests with shareholder value in growth-oriented companies. The structure of the convertible note with a high interest rate and warrants, alongside substantial stock option grants, indicates a strategy to incentivize the CEO while potentially managing immediate cash outflows for compensation.

Comparison to Industry Standards

  • The grant of 2,000,000 stock options and 500,000 shares as a bonus to the CEO is a substantial equity award, comparable to compensation packages seen in small to mid-cap growth companies, particularly in sectors where executive retention and performance incentives are critical.
  • The 18% interest rate on the convertible promissory note is significantly higher than typical corporate borrowing rates from traditional lenders, suggesting either a higher perceived risk by the lender (even if related party) or a strategic choice to provide a strong return to the related party for capital. This rate is more aligned with venture debt or distressed financing terms rather than standard corporate debt.
  • The vesting schedule for the options, with immediate vesting of a portion and accelerated vesting upon specific events (e.g., change of control), is a standard practice in executive compensation to ensure retention and incentivize strategic transactions.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Equity Incentive Plan UsageThe discretionary bonus of 500,000 shares was issued under the registrant's Second Amended and Restated 2022 Equity Incentive Plan.09/09/2025Utilizes an existing plan to incentivize executive performance, aligning management with shareholder interests.

Related Party Transactions

  • Transfer of 200,000 shares from Jacob D. Cohen to The Tiger Cub Trust, which he controls.
  • The Tiger Cub Trust, controlled by Jacob D. Cohen, entered into an agreement to amend and restate a $100,000 promissory note into a convertible note with an 18% interest rate and was granted warrants to purchase 50,000 shares.

Stakeholder Impact

  • Shareholders: Potential future dilution from the conversion of the promissory note and exercise of warrants and stock options. However, increased insider ownership and incentivized management could be seen as positive for long-term value creation.
  • Creditors: The company has a $100,000 convertible promissory note with an 18% interest rate, which represents a financial obligation.

Next Steps

  • Continued service of Jacob D. Cohen with the company for options to vest on 6th, 12th, and 18th month anniversaries of the grant date.
  • Potential conversion of the Amended and Restated Convertible Promissory Note into common stock by May 2, 2026.
  • Potential exercise of warrants to purchase 50,000 shares of common stock by July 21, 2028.
  • Potential exercise of 2,000,000 stock options by September 9, 2035.

Key Dates

DateDescription
07/21/2025Company entered into an Agreement to Amend Promissory Note with Tiger Cub Trust and granted warrants.
09/09/2025Jacob D. Cohen acquired 500,000 shares as a discretionary bonus and 2,000,000 stock options.
05/02/2026Maturity date of the Amended and Restated Convertible Promissory Note.
07/21/2028Expiration date of warrants to purchase 50,000 shares of common stock.
09/09/2035Expiration date of 2,000,000 stock options granted to Jacob D. Cohen.

Recommendation

hold

The filing indicates strong insider commitment through significant equity grants and a convertible note, which can be a positive signal. However, the high 18% interest rate on the convertible note and potential future dilution warrant caution. The overall picture suggests management is incentivized, but the financial terms of the related-party debt need careful consideration, leading to a 'hold' recommendation as investors assess the long-term implications of these transactions.

Keywords

MANGOCEUTICALS, MGRX, Jacob D. Cohen, Insider Trading, Form 4, Stock Options, Convertible Note, Warrants, Equity Incentive Plan, CEO Compensation, Beneficial Ownership

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.